Literature DB >> 16973595

Regulation of the transcription and replication cycle of human cytomegalovirus is insensitive to genetic elimination of the cognate NF-kappaB binding sites in the enhancer.

Montse Gustems1, Eva Borst, Chris A Benedict, Carmen Pérez, Martin Messerle, Peter Ghazal, Ana Angulo.   

Abstract

The role of NF-kappaB in regulating human cytomegalovirus (HCMV) replication and gene transcription remains controversial. Multiple, functional NF-kappaB response elements exist in the major immediate-early promoter (MIEP) enhancer of HCMV, suggesting a possible requirement for this transcription factor in lytic viral replication. Here we demonstrate by generating and analyzing HCMVs with alterations in the MIEP-enhancer that, although this region is essential for HCMV growth, none of the four NF-kappaB response elements contained within the enhancer are required for MIE gene expression or HCMV replication in multiple cell types. These data reveal the robustness of the regulatory network controlling the MIEP enhancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16973595      PMCID: PMC1617225          DOI: 10.1128/JVI.00640-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  NF-kappaB- and c-Jun-dependent regulation of human cytomegalovirus immediate-early gene enhancer/promoter in response to lipopolysaccharide and bacterial CpG-oligodeoxynucleotides in macrophage cell line RAW 264.7.

Authors:  Younghee Lee; Wern-Joo Sohn; Doo-Sik Kim; Hyung-Joo Kwon
Journal:  Eur J Biochem       Date:  2004-03

2.  Promoter-specific trans activation and repression by human cytomegalovirus immediate-early proteins involves common and unique protein domains.

Authors:  R M Stenberg; J Fortney; S W Barlow; B P Magrane; J A Nelson; P Ghazal
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

3.  Cleavage maps for human cytomegalovirus DNA strain AD169 for restriction endonucleases EcoRI, BglII, and HindIII.

Authors:  D H Spector; L Hock; J C Tamashiro
Journal:  J Virol       Date:  1982-05       Impact factor: 5.103

4.  A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus.

Authors:  M Boshart; F Weber; G Jahn; K Dorsch-Häsler; B Fleckenstein; W Schaffner
Journal:  Cell       Date:  1985-06       Impact factor: 41.582

5.  NF-kappaB--a potential therapeutic target for inhibition of human cytomegalovirus (re)activation?

Authors:  Susanna Prösch; Regine Wuttke; Detlev H Krüger; Hans-Dieter Volk
Journal:  Biol Chem       Date:  2002-10       Impact factor: 3.915

6.  Stimulation of the human cytomegalovirus IE enhancer/promoter in HL-60 cells by TNFalpha is mediated via induction of NF-kappaB.

Authors:  S Prösch; K Staak; J Stein; C Liebenthal; T Stamminger; H D Volk; D H Krüger
Journal:  Virology       Date:  1995-04-01       Impact factor: 3.616

7.  Activation of the NF-kappaB pathway in human cytomegalovirus-infected cells is necessary for efficient transactivation of the major immediate-early promoter.

Authors:  Ian B DeMeritt; Liesl E Milford; Andrew D Yurochko
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

8.  RICK activates a NF-kappaB-dependent anti-human cytomegalovirus response.

Authors:  Jan Eickhoff; Miriam Hanke; Matthias Stein-Gerlach; Tan Poi Kiang; Katrin Herzberger; Peter Habenberger; Stefan Müller; Bert Klebl; Manfred Marschall; Thomas Stamminger; Matt Cotten
Journal:  J Biol Chem       Date:  2003-12-10       Impact factor: 5.157

9.  Neutrality of the canonical NF-kappaB-dependent pathway for human and murine cytomegalovirus transcription and replication in vitro.

Authors:  Chris A Benedict; Ana Angulo; Ginelle Patterson; Sukwon Ha; Huang Huang; Martin Messerle; Carl F Ware; Peter Ghazal
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

10.  NF-kappa B activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation.

Authors:  L C Sambucetti; J M Cherrington; G W Wilkinson; E S Mocarski
Journal:  EMBO J       Date:  1989-12-20       Impact factor: 11.598

View more
  25 in total

1.  Phorbol ester-induced human cytomegalovirus major immediate-early (MIE) enhancer activation through PKC-delta, CREB, and NF-kappaB desilences MIE gene expression in quiescently infected human pluripotent NTera2 cells.

Authors:  Xiaoqiu Liu; Jinxiang Yuan; Allen W Wu; Patrick W McGonagill; Courtney S Galle; Jeffery L Meier
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

2.  CMV enhancer-promoter is preferentially active in exocrine cells in vivo.

Authors:  D B Vasey; S G Lillico; H M Sang; T J King; C B A Whitelaw
Journal:  Transgenic Res       Date:  2008-12-16       Impact factor: 2.788

3.  Modulation of the NFκb Signalling Pathway by Human Cytomegalovirus.

Authors:  Meaghan H Hancock; Jay A Nelson
Journal:  Virology (Hyderabad)       Date:  2017-07-31

4.  SAMHD1 Modulates Early Steps during Human Cytomegalovirus Infection by Limiting NF-κB Activation.

Authors:  Eui Tae Kim; Kathryn L Roche; Katarzyna Kulej; Lynn A Spruce; Steven H Seeholzer; Donald M Coen; Felipe Diaz-Griffero; Eain A Murphy; Matthew D Weitzman
Journal:  Cell Rep       Date:  2019-07-09       Impact factor: 9.423

5.  The Elk-1 and serum response factor binding sites in the major immediate-early promoter of human cytomegalovirus are required for efficient viral replication in quiescent cells and compensate for inactivation of the NF-kappaB sites in proliferating cells.

Authors:  Patrizia Caposio; Anna Luganini; Matteo Bronzini; Santo Landolfo; Giorgio Gribaudo
Journal:  J Virol       Date:  2010-02-10       Impact factor: 5.103

6.  The activator protein 1 binding motifs within the human cytomegalovirus major immediate-early enhancer are functionally redundant and act in a cooperative manner with the NF-{kappa}B sites during acute infection.

Authors:  Elena Isern; Montse Gustems; Martin Messerle; Eva Borst; Peter Ghazal; Ana Angulo
Journal:  J Virol       Date:  2010-11-24       Impact factor: 5.103

7.  Reversible inhibition of murine cytomegalovirus replication by gamma interferon (IFN-γ) in primary macrophages involves a primed type I IFN-signaling subnetwork for full establishment of an immediate-early antiviral state.

Authors:  Kai A Kropp; Kevin A Robertson; Garwin Sing; Sara Rodriguez-Martin; Mathieu Blanc; Paul Lacaze; Muhamad F B Noor Hassim; Mizanur R Khondoker; Andreas Busche; Paul Dickinson; Thorsten Forster; Birgit Strobl; Mathias Mueller; Stipan Jonjic; Ana Angulo; Peter Ghazal
Journal:  J Virol       Date:  2011-07-20       Impact factor: 5.103

8.  Human cytomegalovirus microRNA miR-US4-1 inhibits CD8(+) T cell responses by targeting the aminopeptidase ERAP1.

Authors:  Sungchul Kim; Sanghyun Lee; Jinwook Shin; Youngkyun Kim; Irini Evnouchidou; Donghyun Kim; Young-Kook Kim; Young-Eui Kim; Jin-Hyun Ahn; Stanley R Riddell; Efstratios Stratikos; V Narry Kim; Kwangseog Ahn
Journal:  Nat Immunol       Date:  2011-09-04       Impact factor: 25.606

9.  In vivo competence of murine cytomegalovirus under the control of the human cytomegalovirus major immediate-early enhancer in the establishment of latency and reactivation.

Authors:  Montse Gustems; Andreas Busche; Martin Messerle; Peter Ghazal; Ana Angulo
Journal:  J Virol       Date:  2008-08-06       Impact factor: 5.103

Review 10.  New cell-signaling pathways for controlling cytomegalovirus replication.

Authors:  S Roy; R Arav-Boger
Journal:  Am J Transplant       Date:  2014-05-19       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.